BIO-RAD LABORATORIES, INC. - CL B (BIOB)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / CL B
Shares, excl. options Q1 2024
3.66 K
Holdings value Q1 2024
$1.25 M
Value change Q1 2024
+$10.1 K
Grand Portfolio weight change Q1 2024
+0%
Number of holders
7
Number of buys Q1 2024
1
Number of sells Q1 2024
-1
Average buys Q1 2024 %
0%
Average sells Q1 2024 %
0%
CUSIP
090572108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 3.66 K $1.25 M +$10.1 K $340.63 7
2023 Q4 3.63 K $1.16 M -$704 K $318.43 6
2023 Q3 5.61 K $2 M +$711 $355.06 8
2023 Q2 5.61 K $2.1 M -$165 K $376.06 7
2023 Q1 5.93 K $2.75 M +$191 K $464.21 9
2022 Q4 3.64 K $1.51 M +$185 K $412.00 8
2022 Q3 5.3 K $2.22 M -$187 K $417.30 7
2022 Q2 5.66 K $2.75 M +$260 K $493.62 8
2022 Q1 4.97 K $2.85 M -$77.6 M $563.66 6
2021 Q4 109 K $82.3 M -$899 K $754.84 11
2021 Q3 110 K $82.3 M +$501 K $742.96 11
2021 Q2 110 K $70.6 M +$59.5 M $640.80 9
2021 Q1 17.9 K $10.3 M +$3.82 M $571.43 9
2020 Q4 11.3 K $6.57 M -$3.83 M $582.37 5
2020 Q3 17.9 K $9.22 M +$244 K $509.24 6
2020 Q2 17.5 K $7.84 M +$526 K $448.96 6
2020 Q1 16.3 K $5.7 M -$831 K $351.01 6
2019 Q4 18.4 K $6.8 M -$2.98 M $369.95 8
2019 Q3 26.6 K $9.05 M +$48.4 K $339.90 8
2019 Q2 26.4 K $8.2 M +$163 K $312.03 7
2019 Q1 25.9 K $7.85 M -$200 K $303.57 5
2018 Q4 26.7 K $6.14 M -$2.07 M $230.00 7
2018 Q3 32.8 K $10.2 M +$341 K $312.73 7
2018 Q2 31.7 K $9.14 M +$27.8 K $286.51 5
2018 Q1 31.6 K $7.92 M +$109 K $250.28 6
2017 Q4 31.1 K $7.55 M +$180 $238.21 6
2017 Q3 31.1 K $7.03 M -$956 K $223.34 6
2017 Q2 36 K $8.11 M +$1.38 M $225.01 5
2017 Q1 29.9 K $5.98 M -$5 K $199.88 5
2016 Q4 29.9 K $5.48 M +$73.5 K $182.67 6
2016 Q3 29.5 K $4.79 M -$16.6 K $162.38 4
2016 Q2 29.6 K $4.21 M -$34.7 K $141.93 4
2016 Q1 29.9 K $4.04 M -$29.7 K $135.03 5
2015 Q4 30.1 K $4.16 M +$21.8 K $137.97 4
2015 Q3 30 K $4.07 M -$193 K $134.45 5
2015 Q2 31.3 K $4.58 M +$207 K $146.50 6
2015 Q1 29.9 K $4.03 M +$61.4 K $135.00 4
2014 Q4 29.4 K $3.54 M -$10.8 M $120.02 5
2014 Q3 125 K $14.1 M +$27.2 K $113.72 6
2014 Q2 125 K $15 M +$11.4 M $121.50 6
2014 Q1 29.6 K $3.78 M +$31.6 K $127.91 5